Latest Breaking News On - Vanda pharmaceuticals inc - Page 7 : comparemela.com

The Week in Review: April 1-5

From a groundbreaking FDA approval to the hidden toll of COVID-19, here are highlights from the week in Psychiatric Times.

Sleep Month in Review: March 2024

This sleep month in review highlights the 6 top sleep pieces in March, from FDA news, topline data, and pieces exploring how daylight savings and long COVID impact sleep.

Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More - Disc Medicine (NASDAQ:IRON), Bristol-Myers Squibb (NYSE:BMY)

Pipeline and regulatory updates continue to be in focus in the biotech sector. While nothing much came out of bigwigs apart from a few, shares of clinical-stage biotechs like Disc Medicine, Inc.

FDA Approves Iloperidone for Adults with Bipolar 1 Disorder

Vanda Pharmaceuticals announces the FDA approval of iloperidone (Fanapt) for the acute treatment of bipolar 1 disorder.

Vanda Pharmaceuticals' (VNDA) Fanapt Granted FDA Approval for the Acute Treatment of Bipolar I Disorder